+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cresemba"

Cryptococcosis Therapeutics Market Report 2025 - Product Thumbnail Image

Cryptococcosis Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
AntiFungal Drugs Market Overview, 2025-2030 - Product Thumbnail Image

AntiFungal Drugs Market Overview, 2025-2030

  • Report
  • November 2025
  • 101 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Cresemba is a brand of antifungal medication used to treat certain types of fungal infections. It is used to treat infections caused by Aspergillus and Mucorales fungi, which can cause serious and life-threatening infections in people with weakened immune systems. Cresemba is a member of the azole class of antifungal drugs, which work by inhibiting the growth of fungi. It is available in both oral and intravenous formulations. The Cresemba market is a subset of the larger infectious diseases drugs market. It is composed of pharmaceutical companies that produce and market antifungal medications, such as Cresemba. These companies are focused on developing and commercializing treatments for fungal infections, which can be difficult to treat due to their resistance to many existing drugs. Some companies in the Cresemba market include Merck & Co., Pfizer, Astellas Pharma, and Novartis. Show Less Read more